Möchten Sie immer auf dem neuesten Stand bleiben?

Revenue of $95.6 million, recurring revenue growth of 32% Gross margin improves to 48.3% Net income of $11.7 million with Adjusted EBITDA of $12.6 million(1) Total...

Beamr Issues Q2-2025 CEO Letter to Shareholders and Announces its First Half 2025 Financial Results Herzliya, Israel, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Beamr Imaging Ltd. (NASDAQ: BMR), a leader in...

Austin, TX, USA, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Stainless Steel Scrap Market Size, Trends and Insights By Scrap Type (Austenitic...

MZE782 Phase 1 Trial in Healthy Volunteers to Provide Proof of Mechanism Data for Phenylketonuria (PKU) and Chronic Kidney Disease (CKD) Expected in Q3 2025 MZE829 Phase 2 HORIZON Trial Actively...

–   Company reports $12.7 million in revenue in Q2’25, consisting primarily of $4.5 million in YCANTH® revenue, net, reflecting sequential growth of 32.5% over Q1’25 and $8.0 million in milestone...

Chicago, Aug. 11, 2025 (GLOBE NEWSWIRE) -- The global street sweeper market was valued at US$ 2,287.17 million in 2024 and is expected to reach US$ 3,282.05 million by 2033, growing at a CAGR of...

ROAD TOWN, British Virgin Islands, Aug. 09, 2025 (GLOBE NEWSWIRE) -- Ozak AI’s growth is showing no signs of slowing down, with the project now surpassing $1.6 million in total funds raised. Over 90...

Investigational new drug (IND) application cleared by the United States Food and Drug Administration (FDA) for ZW251 with first-in-human studies planned to initiate in 2025China and European approval...

Chicago, Aug. 07, 2025 (GLOBE NEWSWIRE) -- The global AI deception tools market was valued at US$ 680.12 million in 2024 and is expected to US$ 6,361.7 million by 2033, growing at a CAGR of 28.20%...

Platform validating preclinical data presented at EACR 2025 for CAPTN-3 tri-specific T cell engager show synergistic activity of the platform’s masked CD3, NKG2A, and tumor-associated antigen arms ...